Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 May;17(3):586-96.
doi: 10.1208/s12248-015-9718-8. Epub 2015 Feb 19.

Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker Rats

Affiliations
Comparative Study

Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker Rats

Jacob Leander et al. AAPS J. 2015 May.

Abstract

Inclusion of stochastic differential equations in mixed effects models provides means to quantify and distinguish three sources of variability in data. In addition to the two commonly encountered sources, measurement error and interindividual variability, we also consider uncertainty in the dynamical model itself. To this end, we extend the ordinary differential equation setting used in nonlinear mixed effects models to include stochastic differential equations. The approximate population likelihood is derived using the first-order conditional estimation with interaction method and extended Kalman filtering. To illustrate the application of the stochastic differential mixed effects model, two pharmacokinetic models are considered. First, we use a stochastic one-compartmental model with first-order input and nonlinear elimination to generate synthetic data in a simulated study. We show that by using the proposed method, the three sources of variability can be successfully separated. If the stochastic part is neglected, the parameter estimates become biased, and the measurement error variance is significantly overestimated. Second, we consider an extension to a stochastic pharmacokinetic model in a preclinical study of nicotinic acid kinetics in obese Zucker rats. The parameter estimates are compared between a deterministic and a stochastic NiAc disposition model, respectively. Discrepancies between model predictions and observations, previously described as measurement noise only, are now separated into a comparatively lower level of measurement noise and a significant uncertainty in model dynamics. These examples demonstrate that stochastic differential mixed effects models are useful tools for identifying incomplete or inaccurate model dynamics and for reducing potential bias in parameter estimates due to such model deficiencies.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Smoothed histograms over the estimated parameters from 100 simulated data sets. The estimated parameters using the SDE model is shown in blue and the estimates using the ODE model (σ = 0) is shown in purple. The vertical lines show the parameter values used for simulation
Fig. 2
Fig. 2
Plots of the estimated ODE (solid) and SDE (dashed) NiAc model together with the observed concentration time courses of NiAc for the two infusion groups. a 20 μmol kg−1 over 30 min. b 51 μmol kg−1 over 300 min over 300 min. The concentration is shown on a log-linear scale
Fig. 3
Fig. 3
Observed plasma NiAc concentration time profiles together with the estimated ODE (a–c) and SDE (df) NiAc disposition model for three animals (each row) from the first infusion group (20 μmol kg−1 over 30 min)

Similar articles

Cited by

References

    1. Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis: concepts and applications. 4th ed. Swedish Pharmaceutical Press; 2006.
    1. Kristensen NR, Madsen H, Ingwersen SH. Using stochastic differential equations for PK/PD model development. J Pharmacokinet Pharmacodyn. 2005;32(1):109–141. - PubMed
    1. Sheiner L, Beal S. Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-Menten model: Routine clinical pharmacokinetic data. J Pharmacokinet Biopharm. 1980;8(6):553–571. - PubMed
    1. Sheiner L, Beal S. Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic data. J Pharmacokinet Biopharm. 1983;11(3):303–319. - PubMed
    1. Sheiner L, Rosenberg B, Marathe V. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm. 977;5(5):445–479. - PubMed

Publication types

LinkOut - more resources